Catalog |
name |
Description |
price |
R-R-4107 |
Vicasinabin CAS No.1433361-02-4 |
Vicasinabin (RG7774)/CAS No.1433361-02-4 is the potent agonist of cannabinoid receptor 2 (CB2). Vicasinabin has the potential for the research of human diseases including chronic pain, atherosclerosis, regulation of bone mass, neuroinflammation, and other related diseases (extracted from patent US20130116236A1). |
price> |
R-R-4108 |
LH21 CAS No.611207-11-5 |
LH-21/CAS No.611207-11-5 is a potent in vivo neutral cannabinoid CB1 receptor antagonist. LH-21 reduces food intake and body weight gain in obese Zucker rats. , and displays efficacy as a feeding inhibitor. |
price> |
R-R-4109 |
S-777469 CAS No.885496-53-7 |
S-777469/CAS No.885496-53-7 is a selective and orally available cannabinoid type 2 receptor (CB2) agonist with a Ki of 36 nM. S-777469 significantly suppresses compound 48/80-induced scratching behavior in mice in a dose-dependent manner. S-777469 produces its antipruritic effects by inhibiting itch signal transmission through CB2 agonism. |
price> |
R-R-4110 |
2-Arachidonoylglycerol-d8 CAS No.924894-97-3 |
2-Arachidonoylglycerol-d8/CAS No.924894-97-3 is the deuterium labeled 2-Arachidonoylglycerol. 2-Arachidonoylglycerol is a second endogenous cannabinoid ligand in the central nervous system. |
price> |
R-R-4111 |
NESS 0327 CAS No.494844-07-4 |
NESS 0327/CAS No.494844-07-4 is a cannabinoid antagonist with high selectivity for the cannabinoid CB1 receptor. NESS 0327 is more than 60,000-fold selective for the CB1 receptor. |
price> |
R-R-4112 |
CB2 modulator 1 CAS No.666261-80-9 |
CB2 modulator 1 (compound 130)/CAS No.666261-80-9 is a potent CB2 modulator. CB2 modulator 1 has the potential for immunedisorders, inflammation, osteoporosis, renal ischemia. |
price> |
R-R-4113 |
AM-6538 CAS No.1245626-00-9 |
AM6538/CAS No.1245626-00-9 is a long-acting, high affinity and pseudo-irreversible cannabinoid (CB) antagonist. AM6538 is a structural analog of rimonabant. AM6538 can be effectively used to evaluate the apparent efficacy of cannabinoid full and partial agonists. AM6538 may be useful in future studies that require temporary reductions in cannabinoid receptor availability. AM-6538 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups. |
price> |
R-R-4114 |
CB2R antagonist 3 |
CB2R antagonist 3 is a selective antagonist of cannabinoid type 2 receptor (CB2R). CB2R antagonist 3 has high affinity for human CB2R and specific selectivity for CB1R. CB2R antagonist 3 can be combined with CB65 (HY-110047), the activator of CB2R. CB2R antagonist 3 effectively up-regulates the expression of anti-inflammatory cytokines and down-regulates the expression of pro-inflammatory cytokines. |
price> |
R-R-4115 |
CB1/2 agonist 3 CAS No.2772655-86-2 |
CB1/2 agonist 3 (compound 52)/CAS No.2772655-86-2, a potent non-selective cannabinoid ligand, is a CB1/CB2 (cannabinoid receptor) competitive agonist. CB1/2 agonist 3 acts on hCB1 and hCB2 with Ki values of 5.9 nM and 3.5 nM, respectively. |
price> |
R-R-4116 |
2-Arachidonoylglycerol-d5 CAS No.2522598-88-3 |
2-Arachidonoylglycerol-d5/CAS No.2522598-88-3 is the deuterium labeled 2-Arachidonoylglycerol. 2-Arachidonoylglycerol is a second endogenous cannabinoid ligand in the central nervous system. |
price> |